Announcements
Projects
Orgs
Project
Articles 955
Votes 0
Barron's

Authors 80

Bill Alpert
Connor Smith
Jacob Sonenshine
Jack Denton
Logan Moore
Joe Woelfel
Eric J. Savitz
Andrew Bary
Sabrina Escobar
Al Root
Josh Nathan-Kazis
Teresa Rivas
Angela Palumbo
Debbie Carlson
Reshma Kapadia
Nicholas Jasinski
Tae Kim
Elizabeth O'Brien
Ben Levisohn
Lawrence C. Strauss
Lisa Beilfuss
Joe Light
Carleton English
Kenneth Corbin
Neal Templin
Adam Clark
Ed Lin
Lauren R. Rublin
Janet H. Cho
Karishma Vanjani
Jacob Adelman
Andrew Welsch
Jack Hough
Megan Cassella
Lauren Foster
Brian Swint
Shaina Mishkin
Emily Dattilo
Avi Salzman
Michael Kops
Randall W. Forsyth
Fang Block
Callum Keown
Louis Rosenberg
Abby Schultz
Evie Liu
Karen Petrou
Leslie Lipschitz
Thomas Hoenig
Maria Moats
Paul Washington
Nathan Sheets
Rupert Steiner
Megan Leonhardt
Liz Moyer
Julie Gralow
Matt Bemer
Christopher Smart
Lisa Scherzer
Paulo Trevisani
Dow Jones Newswires
Philip Waller
Dan Molinski
Dominic Chopping
Sarah Needleman
Michael W. Peregrine
Craig Mellow
Barron's
Nate Wolf
Elsa Ohlen
Giulia Petroni
Miriam Mukuru
Renae Dyer
Emese Bartha
Mackenzie Tatananni
Adam Levine
Martin Baccardax
Paul R. La Monica
Alex Kozul-Wright
Dan Lam
GM Beats Ford in EV Sales as Rivian Scores on Trucks - Barron's
>2y
Ben and Jerry's Is a Boycott Target Like Bud Light. Investors Shouldn't Worry. - Barron's
>2y
Exxon Stock Is Slipping. Oil Prices Are Falling. - Barron's
>2y
Bitcoin Price Fights for $31,000 as Analysts See More Gains Ahead - Barron's
>2y
Amazon, Microsoft, Rivian, UPS, Netflix, and More Stock Market Movers - Barron's
>2y
Microsoft, Amazon, Nvidia Stocks Hit As China-U.S. Tech War Escalates - Barron's
>2y
Oil Prices Have Stalled Despite Saudi, Russian Production Cuts. Here's Why. - Barron's
>2y
FIS Stock Moves Higher on Report of Private-Equity Interest in Worldpay - Barron's
>2y
AstraZeneca Stock Is Sinking. A Cancer Drug Showed Disappointing Results. - Barron's
>2y
Stock Market Closures, Jobs, the Fed, and More to Watch This Week - Barron's
>2y
Goldman Mulls Exit of Apple Partnership in Further Retreat From Consumer Business - Barron's
>2y
The Stock Market’s Biggest Winners and Losers for First Half of 2023 - Barron's
>2y
Nike's Mixed Earnings Sparks Debate on Wall Street - Barron's
>2y
Constellation Earnings See Boost From Bud Light Backlash. The Stock Is Dropping. - Barron's
>2y
Dylan Mulvaney Speaks Out on Bud Light Uproar - Barron's
>2y
Fidelity Just Filed for Bitcoin ETF, Joining a Crowded Field - Barron's
>2y
Virgin Galactic Stock Falls After Successful First Commercial Spaceflight - Barron's
>2y
JPMorgan, Bank of America, Goldman May Lift Dividends After Stress Tests - Barron's
>2y
Micron Has China Problems, Too. Why the Stock Got Upgraded. - Barron's
>2y
Banks Pass Fed's Stress Test. Now the Focus Is Dividends. - Barron's
>2y
Walgreens Stock Hits Lowest Level Since 2010 as Bullish Analyst Throws in Towel - Barron's
>2y
Nvidia Could Suffer $3 Billion Hit From New China Chip Rules. Buy the Stock Dip. - Barron's
>2y
Stock Market Today: Dow Rises; Walgreens, Lordstown, Eli Lilly and More Movers - Barron's
>2y
Apple Stock Hit a New High Today. Why It’s Still Risky. - Barron's
>2y
Tesla Stock Jumps. No Downgrade and Volvo Help. - Barron's
>2y